Forte Biosciences Inc (FBRX)

Jun 12, 2025

Valkyrie Balance Sheet Opportunities ETF (NYSEARCA:VBB) Trading 0.4% Higher – Here’s Why - Defense World

Jun 12, 2025

Jun 12, 2025

Traders Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - Defense World

Jun 12, 2025

Jun 11, 2025

With Forte Biosciences Up 28%, Insider Buyers Count Their Returns - simplywall.st

Jun 11, 2025

Jun 10, 2025

(FBRX) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 10, 2025

Jun 05, 2025

Forte Biosciences (FBRX) Receives Buy Rating as FB-102 Shows Blockbuster Potential | FBRX Stock News - GuruFocus

Jun 05, 2025

May 30, 2025

Forte Biosciences reports annual meeting results By Investing.com - Investing.com Nigeria

May 30, 2025

May 30, 2025

Forte Biosciences reports annual meeting results - Investing.com

May 30, 2025

May 30, 2025

Forte Biosciences Elects New Directors at Annual Meeting - TipRanks

May 30, 2025

May 29, 2025

Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World

May 29, 2025

May 28, 2025

How the (FBRX) price action is used to our Advantage - news.stocktradersdaily.com

May 28, 2025

May 28, 2025

Pre-market Movers: SPRO, ASBP, IFRX, IMNN... - RTTNews

May 28, 2025

May 22, 2025

Pre-market Movers: VIGL, CVM, KDLY, VTAK... - RTTNews

May 22, 2025

May 19, 2025

Pre-market Movers: HCTI, PTIX, BCLI, AFMD... - RTTNews

May 19, 2025

May 19, 2025

Top Premarket Decliners - marketscreener.com

May 19, 2025

May 16, 2025

Forte Biosciences Reports Increased Losses Amid R&D Expansion - TipRanks

May 16, 2025

May 15, 2025

Forte Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025

May 15, 2025

Forte Biosciences Q1 Operating Expenses USD 16.124 Million - marketscreener.com

May 15, 2025

May 15, 2025

Forte Biosciences (FBRX) Advances Trials for FB102 in Celiac Disease and Vitiligo | FBRX Stock News - GuruFocus

May 15, 2025

May 15, 2025

Forte Biosciences reports Q1 EPS ($1.37), consensus (95c) - TipRanks

May 15, 2025

May 15, 2025

Forte Biosciences, Inc. Announces Results and Provides Update - Eagle-Tribune

May 15, 2025

May 15, 2025

Forte Biosciences Q1: Celiac Disease Trial Results Imminent, New Vitiligo Study Launches - Stock Titan

May 15, 2025

May 15, 2025

Stock Traders Buy High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

May 15, 2025

May 10, 2025

Forte Biosciences (FBRX) Expected to Announce Earnings on Monday - Defense World

May 10, 2025

May 08, 2025

JPMorgan Chase & Co. Trims Stock Holdings in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World

May 08, 2025

May 08, 2025

Royal Bank of Canada Has Lowered Expectations for Zimmer Biomet (NYSE:ZBH) Stock Price - Defense World

May 08, 2025

May 08, 2025

JPMorgan Chase & Co. Buys New Holdings in Innovator U.S. Equity Accelerated ETF – January (BATS:XDJA) - Defense World

May 08, 2025

May 08, 2025

(FBRX) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

May 08, 2025

May 03, 2025

Geode Capital Management LLC Boosts Stock Position in AmpliTech Group, Inc. (NASDAQ:AMPG) - Defense World

May 03, 2025

May 03, 2025

Geode Capital Management LLC Increases Position in Forte Biosciences, Inc. (NASDAQ:FBRX) - Defense World

May 03, 2025

May 03, 2025

Geode Capital Management LLC Increases Position in Lexaria Bioscience Corp. (NASDAQ:LEXX) - Defense World

May 03, 2025

May 01, 2025

Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte Corp - Barchart.com

May 01, 2025

May 01, 2025

Meta Doubles Down on AI: Is the Stock Ready to Skyrocket? - The Globe and Mail

May 01, 2025

Apr 19, 2025

Shining a Light on IL-13: Optimizing Moderate-to-Severe Atopic Dermatitis Treatment in Daily Practice - Healio

Apr 19, 2025

Apr 18, 2025

Forte Biosciences sets Annual Meeting for May 29 By Investing.com - Investing.com Canada

Apr 18, 2025

Apr 18, 2025

Forte Biosciences sets Annual Meeting for May 29 - Investing.com Australia

Apr 18, 2025

Apr 18, 2025

Traders Buy High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - Defense World

Apr 18, 2025

Apr 17, 2025

Mr. Ethan Billings recommends paying close attention to biotech stocks - FinancialContent

Apr 17, 2025

Apr 15, 2025

Profit from Trump’s Tariff Playbook with TipRanks’ New Comparison Tool - The Globe and Mail

Apr 15, 2025

Apr 13, 2025

Nvidia and Broadcom Helped Propel This ETF 18% Higher in a Single Day. Here's Why It's Still a Buy Now. - The Globe and Mail

Apr 13, 2025

Apr 07, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 07, 2025

Apr 07, 2025

Analysts Issue Forecasts for FBRX Q2 Earnings - Defense World

Apr 07, 2025

Apr 07, 2025

Equities Analysts Offer Predictions for FBRX FY2025 Earnings - Defense World

Apr 07, 2025

Apr 06, 2025

(FBRX) Investment Analysis - news.stocktradersdaily.com

Apr 06, 2025

Apr 04, 2025

All You Need to Know About Forte Biosciences (FBRX) Rating Upgrade to Buy - MSN

Apr 04, 2025

Apr 04, 2025

Forte Biosciences (NASDAQ:FBRX) Given New $61.00 Price Target at Chardan Capital - The AM Reporter

Apr 04, 2025

Apr 03, 2025

Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World

Apr 03, 2025

Apr 03, 2025

Chardan Capital Issues Pessimistic Forecast for Forte Biosciences (NASDAQ:FBRX) Stock Price - Defense World

Apr 03, 2025

Apr 02, 2025

Chardan Adjusts Price Target on Forte Biosciences to $61 From $64, Maintains Buy Rating - MarketScreener

Apr 02, 2025

Apr 02, 2025

Forte Biosciences Reports 2024 Progress and Financials - TipRanks

Apr 02, 2025

Apr 01, 2025

Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans? - Yahoo

Apr 01, 2025

Mar 31, 2025

Forte's Celiac Treatment Shows Promise: Zero Dropouts and $58.4M War Chest - Stock Titan

Mar 31, 2025